Core Viewpoint - Beijing Bluecursor Data Technology Group Co., Ltd. has submitted an application for the issuance and listing of overseas listed shares (H shares) on the Hong Kong Stock Exchange, with the application materials published on the exchange's website [1][2]. Group 1 - The company submitted the application for H share issuance and listing on June 25, 2025, and published the application materials on the Hong Kong Stock Exchange website on the same day [1]. - The application materials were prepared in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange, and are subject to updates and revisions [1][3]. - The subscription for this issuance is limited to qualified overseas investors and domestic qualified investors who are authorized to conduct overseas securities investments under Chinese laws and regulations [2]. Group 2 - The company must meet several conditions for the issuance and listing, including obtaining approvals from the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission, the Hong Kong Stock Exchange, and other relevant regulatory bodies, indicating uncertainty in the process [3]. - The company will fulfill its information disclosure obligations in accordance with relevant laws and regulations as the situation progresses [3].

用友网络科技股份有限公司（以下简称"公司"）2025 年第一次临时股东大 会（以下简称"本次股东大会"）采取现场投票与网络投票相结合的方式，现场会 议于 2025 年 6 月 24 日下午 14:00 在用友产业园（北京）中区 8 号楼 E102 会议 室召开。北京市天元律师事务所（以下简称"本所"）接受公司聘任，指派本所律 师参加本次股东大会现场会议进行见证，并根据《中华人民共和国公司法》《中 华人民共和国证券法》（以下简称"《证券法》"）《上市公司股东会规则》（以下 简称"《股东会规则》"）以及《用友网络科技股份有限公司章程》 （以下简称"《公 司章程》"）等有关规定，就本次股东大会的召集、召开程序、出席现场会议人 员的资格、召集人资格、会议表决程序及表决结果等事项出具本法律意见。 为出具本法律意见，本所律师审查了《用友网络科技股份有限公司关于召 开 2025 年第一次临时股东大会的通知》 （以下简称"《召开股东大会通知》"） 《用 北京市天元律师事务所 关于用友网络科技股份有限公司 京天股字（2025）第 418 号 致：用友网络科技股份有限公司 友网络科技股份有限公司第九届董事会第二十一次会议决议公告 ...

证券代码：688008 证券简称：澜起科技 公告编号：2025-030 澜起科技股份有限公司 第三届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 澜起科技股份有限公司（以下简称"公司"）第三届监事会第八次会议于 2025 年 6 月 20 日以现场结合通讯的方式召开，公司于 2025 年 6 月 14 日以邮件方式 向全体监事发出召开本次会议的通知，与会的各位监事已知悉所议事项相关的必 要信息。会议应参加表决的监事 3 人，实际参加表决的监事 3 人，本次会议由监 事会主席夏晓燕召集和主持，本次会议的召集和召开程序符合有关法律、行政法 规、部门规章、规范性文件和《公司章程》的规定，会议决议合法、有效。 二、监事会会议审议情况 经全体监事表决，形成决议如下： 为深化公司的国际化战略布局，持续吸引并集聚优秀的研发与管理人才，增强境 外融资能力，进一步提升公司核心竞争力，根据公司发展战略及运营需要，监事会 同意公司发行境外上市股份 H 股股票并在香港联合交易所有限公司（以下简称 ...

议案一：《关于公司发行H股股票并在香港联合交易所有限公司上市的议案》 议案二：《关于公司发行H股股票并在香港联合交易所有限公司上市方案的 议案》 议案三：《关于公司发行H股募集资金使用计划的议案》 议案四：《关于公司申请转为境外募集股份有限公司的议案》 议案五：《关于公司发行H股股票前滚存利润分配方案的议案》 议案六：《关于取消监事会的议案》 议案七：《关于修订 <公司章程> 及相关议事规则的议案》 议案八：《关于修订公司于H股发行上市后适用的 <公司章程 草案="草案"> 及相 关议事规则（草案）的议案》 议案》 议案》 议案九：《关于修订公司于H股发行上市后适用的内部治理制度的议案》 》 议案十：《关于公司聘请H股发行并上市的审计机构的议案》 议案十一：《关于增补董事的议案》 议案十二：《关于确定公司董事角色及董事会专门委员会成员的议案》 议案十三：《关于购买公司董事和高级管理人员及相关人员责任保险和招股 说明书责任保险的议案》 议案十四：《关于提请股东会授权董事会及其授权人士全权办理公司发行H 股并上市相关事宜的议案》 为了维护全体股东的合法权益，确保股东会的正常秩序和议事效率，保证大会 的顺利进行，根 ...

Core Viewpoint - The company, Shanjin International Gold Co., Ltd., has authorized its management to initiate the preparation for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance its global strategy and optimize its capital structure [1][2]. Group 1: Company Actions - The board of directors held a meeting on June 19, 2025, where all nine directors participated and unanimously approved the proposal to authorize management to start the preparatory work for the overseas issuance of H-shares [1]. - The company aims to deepen its global strategy, accelerate overseas business development, and leverage international capital market advantages through this H-share issuance [2]. Group 2: Regulatory Compliance - The issuance and listing of H-shares will comply with relevant laws and regulations, including the Company Law of the People's Republic of China and the listing rules of the Hong Kong Stock Exchange [2]. - Specific details regarding the H-share issuance and listing are still under discussion with relevant intermediaries, and the final plan will require approval from the board, shareholders, and regulatory bodies [2].

企业上市是公司发展到一定阶段后，为了拓展筹资渠道、提升品牌形象和增强市场竞争力而采取的重要战略 步骤。那么，对于选择在境内还是境外上市，是企业在上市过程中面临的一个关键决策。 ✅境内上市：对企业的盈利指标、股东数量等有着明确的数字规定，而且从前期筹备到正式上市基本需要花 费二到三年的时间。 ✅境外上市：体系相对完善，市场相对成熟，因此上市运作的速度更快，大概只需要一年左右的时间。 3、盈利要求不同 接下来通过详细的对比分析，帮助企业定位目标市场，做出明智的选择。 （图片来源于网络） 一、境内外上市的主要差别 1、监管环境不同 ✅境内上市：要经过中国证监会的严格审核，监管较为严格，审批流程较长，上市门槛较高。 ✅境外上市：如美国、香港等地，多采用注册制，上市流程相对简单，审批速度较快，企业自主性较强，但 要符合当地证券监管机构的要求。 2、上市周期不同 ✅境内上市：对企业的盈利能力、资产规模、股权结构等有较高的要求。例如，上交所主板要求企业最近三 年连续盈利，且累计净利润不低于3000万元人民币。 ✅境外上市：相对来说，境外上市的门槛较低。如纳斯达克市场对企业的盈利能力要求相对宽松，允许一些 尚未盈利但具有高成 ...

根据近期中国证监会提出的"优化境外上市备案制度"、"完善境内外上市联动机制"等政策,目前中国监 管机构整体支持企业赴境外融资,提供宽松环境;同时伴随近期中美经贸磋商机制的新一轮沟通,中美资本 市场层面也将增加更多的互动与认可。 根据近期零碳环保披露财务报告,2024年全年营收45亿,同比实现较大幅度增长,企业的战略发展、市场规 模效应得以进一步体现。 笔者认为在宏观环境、政策支持、企业竞争力均利好的背景下,零碳环保将较快可以完成在纳斯达克交 易所IPO上市挂牌。 本次IPO的中介机构如下: 在全球绿色经济浪潮日益高涨的背景下,专注于互联网+资源回收数字化解决方案的Carbon Zero Technologies International Inc.(零碳环保,代码:CZTI)此前境外上市备案通知函于2025年5月30日到期。 从美国证监会等监管机构来看,零碳环保(CZTI)已经取得SEC出具的新股发行注册函(Form 8-A12B)。 根据其他案例,此前文远知行(代码:WRD)于2024年8月27日境外发行备案通知书到期,然后开展境外上市 备案通知书延期工作,于2024年10月28日完成IPO,备案失效到IP ...

Core Viewpoint - The company plans to initiate the process for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance its global strategy and capital strength [1] Group 1 - The fourth board meeting of the company is scheduled for June 10, 2025, to review the proposal for H-share issuance [1] - The company aims to strengthen its international capital operation platform and overall competitiveness through this H-share listing [1] - The board intends to authorize the management to start preliminary preparations for the H-share listing [1] Group 2 - The company will discuss specific steps for the H-share listing with relevant intermediaries [1] - Details regarding the H-share listing are yet to be determined [1]

Core Viewpoint - Chao Hong Ji (潮宏基) plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy, brand image, and competitiveness [1][2] Financial Performance - In 2024, the company achieved a revenue of 6.52 billion yuan, a year-on-year increase of 10.48%, while net profit attributable to shareholders decreased by 41.91% to 194 million yuan [2][3] - The net profit excluding non-recurring gains and losses was 187 million yuan, down 38.72% compared to the previous year [2][3] - The net cash flow from operating activities was 435 million yuan, a decline of 29.22% year-on-year [2][3] Recent Quarterly Results - For Q1 2025, the company reported a revenue of 2.25 billion yuan, reflecting a year-on-year growth of 25.36% [4] - The net profit attributable to shareholders for Q1 2025 was 189 million yuan, up 44.38% year-on-year [4] - The net profit excluding non-recurring gains and losses for Q1 2025 was 188 million yuan, an increase of 46.17% compared to the same period last year [4] Shareholding Structure - As of the end of Q1 2025, the controlling shareholder, Shantou Chao Hong Ji Investment Co., held 28.55% of the shares, with 31% of these shares pledged [4][5] - The chairman and general manager, Liao Chuangbin, holds 3.04% of the shares, with 48% of his holdings also pledged [4][5]

Group 1 - The Hong Kong Securities and Futures Commission (SFC) issued a restriction notice to Huanlian International Asset Management due to concerns about its reliability, integrity, and ability to conduct regulated activities properly [1] - The SFC's action reflects high standards required from market participants to ensure market fairness and transparency [1] Group 2 - The SFC is collaborating with global regulatory bodies to curb illegal activities by financial influencers who promote financial products on social media, potentially putting millions of users at risk [2] - The effectiveness of the SFC's efforts will be enhanced through cooperation with other regulators, emphasizing the need for investors to verify the regulatory status and credibility of financial influencers before making investment decisions [2] Group 3 - Baize Medical Group passed the Hong Kong Stock Exchange (HKEX) listing hearing and is expected to list soon, focusing on oncology medical services through ownership and management of multiple hospitals [3] - The projected revenues for Baize Medical from 2022 to 2024 are 803 million, 1.072 billion, and 1.189 billion respectively, indicating growth potential in the healthcare sector [3] Group 4 - Stone Technology, a manufacturer of smart cleaning robots, announced plans to issue shares and list on the HKEX to enhance its global brand recognition and competitiveness [4] - This move aims to optimize capital structure, diversify financing channels, and strengthen corporate governance, positioning the company to capitalize on the growing demand for smart cleaning robots [4] Group 5 - The latest performance of the Hong Kong stock market shows the Hang Seng Index at 23,792.54, down 0.48%, the Hang Seng Tech Index at 5,286.52, down 0.63%, and the National Enterprises Index at 8,629.75, also down 0.63% [5]